JP Morgan Chase’s Zimmer Biomet ZBH Stock Holding History

JP Morgan Chase’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-69,600	Closed	-$7.35M	–	7795
2024 Q4	$7.35M	Hold	69,600	–	–	﹤0.01%	3006
2024 Q3	$7.51M	Hold	69,600	–	–	﹤0.01%	2870
2024 Q2	$7.55M	Sell	69,600 -40,000	-36%	-$4.72M	﹤0.01%	2705
2024 Q1	$14.5M	Buy	109,600 +44,700	+69%	+$5.58M	﹤0.01%	2161
2023 Q4	$7.9M	Buy	64,900 +62,400	+2,496%	+$6.96M	﹤0.01%	2687
2023 Q3	$281K	Buy	+2,500	New	+$317K	﹤0.01%	4842
2019 Q2	–	Sell	-51,500	Closed	-$6.38M	–	6049
2019 Q1	$6.38M	Buy	+51,500	New	+$5.85M	﹤0.01%	2393
2017 Q4	–	Sell	-19,570	Closed	-$2.2M	–	5607
2017 Q3	$2.2M	Buy	+19,570	New	+$2.26M	﹤0.01%	3097
2017 Q2	–	Sell	-21,630	Closed	-$2.56M	–	5263
2017 Q1	$2.56M	Buy	21,630 +5,047	+30%	+$572K	﹤0.01%	2889
2016 Q4	$1.66M	Buy	+16,583	New	+$1.78M	﹤0.01%	3184

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase's ZBH Position: Q2 2026 in Review

JP Morgan Chase reduced its Zimmer Biomet (ZBH) stake by 1.5% in Q2 2026, selling an estimated $1.1M and leaving 815,914 shares worth $74.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

JP Morgan Chase first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.69B in Q3 2021. 907 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

JP Morgan Chase held 815,914 shares of Zimmer Biomet worth $74.4M as of Q2 2026.
JP Morgan Chase sold 12,506 Zimmer Biomet shares in Q2 2026, an estimated $1.1M.
Zimmer Biomet made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1213 holding.
JP Morgan Chase first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
JP Morgan Chase's Zimmer Biomet position peaked at $1.69B in Q3 2021.
907 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.